AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript
Company Overview - AVITA Medical is currently undergoing a leadership transition with Cary Vance serving as Interim CEO and David O'Toole as CFO [2][3] - The company is focused on improving its business predictability and credibility following a challenging period in 2025 [3] Business Goals - The primary objective for the fourth quarter was to gain a better understanding of the business to enable accurate forecasting, which was successfully achieved [4] - Looking ahead to 2026, the company aims to grow in a disciplined and methodical manner [4]